-
Signature
-
/s/ Brett Hagen, as Attorney-in-Fact
-
Stock symbol
-
ALVR
-
Transactions as of
-
Feb 2, 2023
-
Transactions value $
-
$0
-
Form type
-
4
-
Date filed
-
2/3/2023, 04:00 PM
Transactions Table
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
transaction |
ALVR |
Common Stock |
Award |
$0 |
+158K |
+15.29% |
$0.00 |
1.19M |
Feb 2, 2023 |
Direct |
F1 |
holding |
ALVR |
Common Stock |
|
|
|
|
|
16.7M |
Feb 2, 2023 |
Shares held by ElevateBio LLC |
F2 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
transaction |
ALVR |
Stock Option (Right to Buy) |
Award |
$0 |
+293K |
+40.63% |
$0.00 |
1.01M |
Feb 2, 2023 |
Common Stock |
293K |
$6.65 |
Direct |
F3 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Explanation of Responses:
Remarks:
Officer Title: President and Chief Financial Officer